Temasek-backed Chinese biotech firm D3 Bio raises $62m in Series A+ round

European life sciences investment firm Medicxi led the round with a $40 million investment.

Related Keywords

Boyu ,Xizang ,China ,Zhongshan ,Jiangxi ,Shanghai ,Chinese ,Daiichi Sankyo ,George Chen ,Antoine Yver ,Novartis ,Alphabet Inc ,Johnson ,Astrazeneca ,Temasek ,Singapore Temasek Holdings ,Temasek Holdings ,Boyu Capital ,Matrix Partners China ,Wuxi Apptec ,Wuxi Apptech ,Sequoia Capital ,